Upgrade to SI Premium - Free Trial

Prothena Corp (PRTA) PT Lowered to $83 at JMP Securities

May 9, 2024 3:11 AM
JMP Securities analyst Jason Butler lowered the price target on Prothena Corp (NASDAQ: PRTA) to $83.00 (from $85.00) while maintaining a Market Outperform rating.

Categories

Analyst PT Change

Next Articles